BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 281 filers reported holding BLUEBIRD BIO INC in Q2 2020. The put-call ratio across all filers is 1.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $393,000 | +54.7% | 94,875 | +81.2% | 0.00% | +100.0% |
| Q1 2022 | $254,000 | -82.5% | 52,372 | -31.0% | 0.00% | -87.5% |
| Q3 2021 | $1,450,000 | -47.4% | 75,890 | -11.9% | 0.01% | -42.9% |
| Q2 2021 | $2,755,000 | +356.1% | 86,133 | +329.7% | 0.01% | +366.7% |
| Q1 2021 | $604,000 | -17.6% | 20,043 | +25.7% | 0.00% | -57.1% |
| Q1 2020 | $733,000 | +124.2% | 15,950 | +328.2% | 0.01% | +250.0% |
| Q4 2019 | $327,000 | -89.8% | 3,725 | -80.3% | 0.00% | -93.1% |
| Q2 2015 | $3,191,000 | -68.2% | 18,950 | -77.2% | 0.03% | -65.5% |
| Q1 2015 | $10,024,000 | +93.4% | 83,000 | +46.9% | 0.08% | +100.0% |
| Q4 2014 | $5,182,000 | +2310.2% | 56,500 | +841.7% | 0.04% | +2000.0% |
| Q3 2014 | $215,000 | – | 6,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 6,335,528 | $40,104,000 | 4.92% |
| qPULA Trading Management LP | 14,344 | $91,000 | 0.80% |
| Frazier Life Sciences Management, L.P. | 1,440,757 | $9,120,000 | 0.70% |
| Ikarian Capital, LLC | 462,628 | $2,928,000 | 0.58% |
| Birchview Capital, LP | 98,000 | $620,000 | 0.44% |
| HealthCor Management, L.P. | 455,000 | $2,880,000 | 0.36% |
| Financial Advocates Investment Management | 45,071 | $3,538,000 | 0.29% |
| PDT Partners, LLC | 262,767 | $1,663,000 | 0.25% |
| Monaco Asset Management SAM | 80,000 | $506,000 | 0.19% |
| Summit X, LLC | 103,424 | $651,000 | 0.19% |